- Home
- SUNS vs FBRX Comparison
SUNS vs FBRX Comparison
Compare SUNS & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUNS
- FBRX
- Stock Information
- Founded
- SUNS 2023
- FBRX N/A
- Country
- SUNS United States
- FBRX United States
- Employees
- SUNS N/A
- FBRX N/A
- Industry
- SUNS Real Estate Investment Trusts
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- SUNS Real Estate
- FBRX Health Care
- Exchange
- SUNS Nasdaq
- FBRX Nasdaq
- Market Cap
- SUNS 142.3M
- FBRX 154.5M
- IPO Year
- SUNS N/A
- FBRX N/A
- Fundamental
- Price
- SUNS $10.48
- FBRX $11.60
- Analyst Decision
- SUNS Strong Buy
- FBRX Strong Buy
- Analyst Count
- SUNS 3
- FBRX 2
- Target Price
- SUNS $13.67
- FBRX $61.00
- AVG Volume (30 Days)
- SUNS 63.8K
- FBRX 73.6K
- Earning Date
- SUNS 08-07-2025
- FBRX 08-13-2025
- Dividend Yield
- SUNS 11.45%
- FBRX N/A
- EPS Growth
- SUNS N/A
- FBRX N/A
- EPS
- SUNS 1.02
- FBRX N/A
- Revenue
- SUNS $13,066,680.00
- FBRX N/A
- Revenue This Year
- SUNS $148.89
- FBRX N/A
- Revenue Next Year
- SUNS $43.47
- FBRX N/A
- P/E Ratio
- SUNS $10.28
- FBRX N/A
- Revenue Growth
- SUNS 1342.10
- FBRX N/A
- 52 Week Low
- SUNS $7.80
- FBRX $4.11
- 52 Week High
- SUNS $15.74
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- SUNS N/A
- FBRX 53.91
- Support Level
- SUNS N/A
- FBRX $10.02
- Resistance Level
- SUNS N/A
- FBRX $10.99
- Average True Range (ATR)
- SUNS 0.00
- FBRX 0.86
- MACD
- SUNS 0.00
- FBRX -0.06
- Stochastic Oscillator
- SUNS 0.00
- FBRX 60.78
About SUNS Sunrise Realty Trust Inc. Common Stock
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).